Report Detail

Pharma & Healthcare Global Companion Animal Pharmaceutical Market Status and Forecast 2021-2027

  • RnM4337166
  • |
  • 26 July, 2021
  • |
  • Global
  • |
  • 159 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Companion Animal Pharmaceutical Market Status and Forecast (2016-2027)
      • 1.3.2 Global Companion Animal Pharmaceutical Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Companion Animal Pharmaceutical Supply by Company

    • 2.1 Global Companion Animal Pharmaceutical Sales Volume by Company
    • 2.2 Global Companion Animal Pharmaceutical Sales Value by Company
    • 2.3 Global Companion Animal Pharmaceutical Price by Company
    • 2.4 Companion Animal Pharmaceutical Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Companion Animal Pharmaceutical Market Status by Type

    • 3.1 Companion Animal Pharmaceutical Type Introduction
      • 3.1.1 Infectious Diseases
      • 3.1.2 Dermatologic Diseases
      • 3.1.3 Pain
      • 3.1.4 Orthopedic Diseases
      • 3.1.5 Behavioral Diseases
      • 3.1.6 Other Indications
    • 3.2 Global Companion Animal Pharmaceutical Market by Type
      • 3.2.1 Global Companion Animal Pharmaceutical Sales Volume by Type (2016-2021)
      • 3.2.2 Global Companion Animal Pharmaceutical Sales Value by Type (2016-2021)
      • 3.2.3 Global Companion Animal Pharmaceutical Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Companion Animal Pharmaceutical Market Status by Application

    • 4.1 Companion Animal Pharmaceutical Segment by Application
      • 4.1.1 Dogs
      • 4.1.2 Cats
      • 4.1.3 Other
    • 4.2 Global Companion Animal Pharmaceutical Market by Application
      • 4.2.1 Global Companion Animal Pharmaceutical Sales Volume by Application (2016-2021)
      • 4.2.2 Global Companion Animal Pharmaceutical Sales Value by Application (2016-2021)
      • 4.2.3 Global Companion Animal Pharmaceutical Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Companion Animal Pharmaceutical Market Status by Region

    • 5.1 Global Companion Animal Pharmaceutical Market by Region
      • 5.1.1 Global Companion Animal Pharmaceutical Sales Volume by Region
      • 5.1.2 Global Companion Animal Pharmaceutical Sales Value by Region
    • 5.2 North America Companion Animal Pharmaceutical Market Status
    • 5.3 Europe Companion Animal Pharmaceutical Market Status
    • 5.4 Asia Pacific Companion Animal Pharmaceutical Market Status
    • 5.5 Central & South America Companion Animal Pharmaceutical Market Status
    • 5.6 Middle East & Africa Companion Animal Pharmaceutical Market Status

    6 North America Companion Animal Pharmaceutical Market Status

    • 6.1 North America Companion Animal Pharmaceutical Market by Country
      • 6.1.1 North America Companion Animal Pharmaceutical Sales Volume by Country (2016-2021)
      • 6.1.2 North America Companion Animal Pharmaceutical Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Companion Animal Pharmaceutical Market Status

    • 7.1 Europe Companion Animal Pharmaceutical Market by Country
      • 7.1.1 Europe Companion Animal Pharmaceutical Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Companion Animal Pharmaceutical Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Companion Animal Pharmaceutical Market Status

    • 8.1 Asia Pacific Companion Animal Pharmaceutical Market by Country
      • 8.1.1 Asia Pacific Companion Animal Pharmaceutical Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Companion Animal Pharmaceutical Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Companion Animal Pharmaceutical Market Status

    • 9.1 Central & South America Companion Animal Pharmaceutical Market by Country
      • 9.1.1 Central & South America Companion Animal Pharmaceutical Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Companion Animal Pharmaceutical Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Companion Animal Pharmaceutical Market Status

    • 10.1 Middle East & Africa Companion Animal Pharmaceutical Market by Country
      • 10.1.1 Middle East & Africa Companion Animal Pharmaceutical Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Companion Animal Pharmaceutical Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Companion Animal Pharmaceutical Manufacturing Cost Analysis
    • 11.5 Companion Animal Pharmaceutical Sales Channel and Distributors Analysis
      • 11.5.1 Companion Animal Pharmaceutical Sales Channel
      • 11.5.2 Companion Animal Pharmaceutical Distributors
    • 11.6 Companion Animal Pharmaceutical Downstream Major Buyers

    12 Global Companion Animal Pharmaceutical Market Forecast by Type and by Application

    • 12.1 Global Companion Animal Pharmaceutical Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Companion Animal Pharmaceutical Forecast by Type
      • 12.2.1 Global Companion Animal Pharmaceutical Sales Volume Forecast by Type
      • 12.2.2 Global Companion Animal Pharmaceutical Sales Value Forecast by Type
      • 12.2.3 Global Companion Animal Pharmaceutical Price Forecast by Type
    • 12.3 Global Companion Animal Pharmaceutical Forecast by Application
      • 12.3.1 Global Companion Animal Pharmaceutical Sales Volume Forecast by Application
      • 12.3.2 Global Companion Animal Pharmaceutical Sales Value Forecast by Application
      • 12.3.3 Global Companion Animal Pharmaceutical Price Forecast by Application

    13 Global Companion Animal Pharmaceutical Market Forecast by Region/Country

    • 13.1 Global Companion Animal Pharmaceutical Market Forecast by Region (2022-2027)
      • 13.1.1 Global Companion Animal Pharmaceutical Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Companion Animal Pharmaceutical Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zoetis
      • 14.1.1 Company Information
      • 14.1.2 Companion Animal Pharmaceutical Product Introduction
      • 14.1.3 Zoetis Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Virbac
      • 14.2.1 Company Information
      • 14.2.2 Companion Animal Pharmaceutical Product Introduction
      • 14.2.3 Virbac Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Vetoquinol
      • 14.3.1 Company Information
      • 14.3.2 Companion Animal Pharmaceutical Product Introduction
      • 14.3.3 Vetoquinol Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Parnell
      • 14.4.1 Company Information
      • 14.4.2 Companion Animal Pharmaceutical Product Introduction
      • 14.4.3 Parnell Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Ouro Fino Saude
      • 14.5.1 Company Information
      • 14.5.2 Companion Animal Pharmaceutical Product Introduction
      • 14.5.3 Ouro Fino Saude Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Merck Animal Health
      • 14.6.1 Company Information
      • 14.6.2 Companion Animal Pharmaceutical Product Introduction
      • 14.6.3 Merck Animal Health Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Meiji
      • 14.7.1 Company Information
      • 14.7.2 Companion Animal Pharmaceutical Product Introduction
      • 14.7.3 Meiji Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Elanco Animal Health
      • 14.8.1 Company Information
      • 14.8.2 Companion Animal Pharmaceutical Product Introduction
      • 14.8.3 Elanco Animal Health Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Dechra Veterinary Products
      • 14.9.1 Company Information
      • 14.9.2 Companion Animal Pharmaceutical Product Introduction
      • 14.9.3 Dechra Veterinary Products Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Ceva
      • 14.10.1 Company Information
      • 14.10.2 Companion Animal Pharmaceutical Product Introduction
      • 14.10.3 Ceva Companion Animal Pharmaceutical Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Boehringer Ingelheim
    • 14.12 Bayer Animal Health

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Companion Animal Pharmaceutical market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Companion Animal Pharmaceutical industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Companion Animal Pharmaceutical market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Companion Animal Pharmaceutical Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Companion Animal Pharmaceutical market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Companion Animal Pharmaceutical Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Companion Animal Pharmaceutical industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Infectious Diseases
      Dermatologic Diseases
      Other Indications

      Segmented by Application
      Dogs
      Cats
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Vetoquinol
      Parnell
      Ouro Fino Saude
      Merck Animal Health
      Meiji
      Elanco Animal Health
      Dechra Veterinary Products
      Ceva
      Boehringer Ingelheim
      Bayer Animal Health


      Summary:
      Get latest Market Research Reports on Companion Animal Pharmaceutical. Industry analysis & Market Report on Companion Animal Pharmaceutical is a syndicated market report, published as Global Companion Animal Pharmaceutical Market Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Companion Animal Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,181.36
      3,272.04
      4,362.72
      2,535.98
      3,803.97
      5,071.96
      326,548.40
      489,822.60
      653,096.80
      219,924.00
      329,886.00
      439,848.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report